Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Wells A. Messersmith
Antonio Jimeno
David Ettinger
Dan Laheru
Julie Brahmer
Dina Lansey
Yasmin Khan
Ross C. Donehower
Yusri Elsayed
Peter Zannikos
Manuel Hidalgo
机构：
[1] University of Colorado Cancer Center,
[2] Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,undefined
[3] Johnson & Johnson Pharmaceutical Research & Development,undefined
[4] L.L.C.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词：
Dose-finding; Phase I; Gemcitabine; Pharmacokinetics; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 188
页数：7
相关论文
共 50 条
  • [31] Population Pharmacokinetic Meta-Analysis of Trabectedin (ET-743, Yondelis®) in Cancer Patients
    Juan Jose Perez-Ruixo
    Peter Zannikos
    Sarapee Hirankam
    Kim Stuyckens
    Elizabeth A. Ludwig
    Arturo Soto-Matos
    Luis Lopez-Lazaro
    Joel S. Owen
    Clinical Pharmacokinetics, 2007, 46 : 867 - 884
  • [32] Phase I trial of weekly irinotecan plus docetaxel in patients with advanced solid tumors.
    Font, A
    Sánchez, JM
    Guillot, M
    Abad, A
    Taron, M
    Margelí, M
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [33] Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors
    Bailey, Howard H.
    Alberti, Dona B.
    Thomas, James P.
    Mulkerin, Daniel L.
    Binger, Kimberly A.
    Gottardis, Marco M.
    Martell, Robert E.
    Wilding, George
    CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3623 - 3629
  • [34] A phase I trial of romidepsin in combination with gemcitabine in patients with pancreatic and other advanced solid tumors
    Doss, H. H.
    Jones, S. F.
    Infante, J. R.
    Spigel, D. R.
    Willcutt, N.
    Lamar, R.
    Barton, J.
    Keegan, M.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
    Ghalib, Mohammad H.
    Pulla, Mariano Provencio
    Luken, Maria J. De Miguel
    de Juan, Virginia Calvo
    Chaudhary, Imran
    Hammami, M. Bakri
    Vikash, Sindhu
    Maitra, Radhashree
    Martinez, Sara
    Kahatt, Carmen
    Extremera, Sonia
    Fudio, Salvador
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 481 - 491
  • [36] Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors
    Maurel, J
    Zorrilla, M
    Puertolas, T
    Antón, A
    Herrero, A
    Artal, A
    Alonso, V
    Martinez-Trufero, J
    Puertas, MD
    ANTI-CANCER DRUGS, 2001, 12 (09) : 713 - 717
  • [37] Updated results of Phase II study of trabectedin (ET-743) in pretreated patients with advanced/metastatic soft tissue sarcoma from a single institute
    Mohan, V.
    Chawla, T.
    Alzwahereh, K.
    Jeong, W.
    Kita, K. Y.
    Chua, V. S.
    Kalra, A.
    Rana, G. S.
    Chawla, S. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
    Randall Brand
    Mary Capadano
    Margaret Tempero
    Investigational New Drugs, 1997, 15 : 331 - 341
  • [39] A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
    Brand, R
    Capadano, M
    Tempero, M
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (04) : 331 - 341
  • [40] Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
    Tassinari, D
    Pasini, G
    Arcangeli, V
    Panzini, I
    Drudi, G
    Gianni, L
    Oliverio, G
    Sartori, S
    Fochessati, F
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
12345